SAM
BBIO icon

Sectoral Asset Management’s BridgeBio Pharma BBIO Stock Holding History

Sectoral Asset Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Sell
4,100
-4,000
-49% -$280K 0.21% 71
2026
Q1 		$687K Sell
8,100
-3,070
-27% -$223K 0.57% 47
2025
Q4 		$854K Sell
11,170
-2,480
-18% -$163K 0.68% 39
2025
Q3 		$709K Sell
13,650
-2,435
-15% -$119K 0.44% 61
2025
Q2 		$695K Hold
16,085
– – 0.46% 58
2025
Q1 		$556K Buy
16,085
+4,585
+40% +$155K 0.43% 52
2024
Q4 		$316K Sell
11,500
-3,585
-24% -$92.6K 0.21% 64
2024
Q3 		$384K Sell
15,085
-450
-3% -$11.8K 0.23% 67
2024
Q2 		$394K Sell
15,535
-570
-4% -$15.6K 0.16% 74
2024
Q1 		$498K Buy
16,105
+3,150
+24% +$107K 0.2% 71
2023
Q4 		$523K Sell
12,955
-167,240
-93% -$5.02M 0.23% 77
2023
Q3 		$4.75M Buy
+180,195
New +$5.11M 0.93% 46
2022
Q1 		– Sell
-282,950
Closed -$4.72M – 109
2021
Q4 		$4.72M Sell
282,950
-190,000
-40% -$8.04M 0.71% 55
2021
Q3 		$22.2M Buy
472,950
+147,100
+45% +$7.88M 1.84% 12
2021
Q2 		$19.9M Buy
325,850
+142,750
+78% +$8.15M 1.61% 19
2021
Q1 		$11.3M Buy
183,100
+177,100
+2,952% +$11.6M 0.86% 49
2020
Q4 		$427K Buy
+6,000
New +$289K 0.03% 94

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Sectoral Asset Management's BBIO Position: Q2 2026 in Review

Sectoral Asset Management reduced its BridgeBio Pharma (BBIO) stake by 49% in Q2 2026, selling an estimated $280K and leaving 4,100 shares worth $305K. The position accounts for 0.21% of the portfolio, ranked #71.

Sectoral Asset Management first reported a position in BBIO in Q4 2020 and has held it in 17 quarters since. The position peaked at $22.2M in Q3 2021. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Sectoral Asset Management held 4,100 shares of BridgeBio Pharma worth $305K as of Q2 2026.
  • Sectoral Asset Management sold 4,000 BridgeBio Pharma shares in Q2 2026, an estimated $280K.
  • BridgeBio Pharma made up 0.21% of Sectoral Asset Management's portfolio in Q2 2026, its #71 holding.
  • Sectoral Asset Management first reported a position in BridgeBio Pharma in Q4 2020 and has held it in 17 quarters since.
  • Sectoral Asset Management's BridgeBio Pharma position peaked at $22.2M in Q3 2021.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.